Literature DB >> 22958770

Fatal hemorrhage in cerebral proliferative angiopathy.

H Maekawa1, M Tanaka, H Hadeishi.   

Abstract

Cerebral proliferative angiopathy (CPA) is a rare vascular abnormality with several angiomorphological features that are distinct from brain arteriovenous malformations (AVMs). The natural history of CPAs indicates a lower risk for hemorrhage compared to brain AVMs. A 62-year-old woman presented with gait instability and dysarthria. MRI and angiography revealed a diffuse vascular network involving the tectum and cerebellar vermis with intermingled brain parenchyma. This lesion had no dominant feeder, high-flow arteriovenous shunt, flow-related aneurysm or highly dilated veins on angiogram. These findings were consistent with a diagnosis of CPA. During follow-up, she developed progressive gait instability and eye movement abnormalities, but no remarkable change was detected on the repeated MRI and angiography. Nine years later, she died of mesencephalic hemorrhage originating from the CPA. To the best of our knowledge, this is the first description of a patient with CPA who died as a result of the initial hemorrhage. It is important to recognize that a part of CPAs is aggressive and can be more vulnerable to critical hemorrhage.

Entities:  

Mesh:

Year:  2012        PMID: 22958770      PMCID: PMC3442305          DOI: 10.1177/159101991201800310

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  10 in total

1.  Diffuse arteriovenous malformations: a clinical, radiological, and pathological description.

Authors:  L S Chin; C Raffel; I Gonzalez-Gomez; S L Giannotta; J G McComb
Journal:  Neurosurgery       Date:  1992-11       Impact factor: 4.654

2.  Radiosurgery for arteriovenous malformations.

Authors:  Bruce E Pollock; Fredric B Meyer
Journal:  J Neurosurg       Date:  2004-09       Impact factor: 5.115

Review 3.  Treatment of brain arteriovenous malformations: a systematic review and meta-analysis.

Authors:  Janneke van Beijnum; H Bart van der Worp; Dennis R Buis; Rustam Al-Shahi Salman; L Jaap Kappelle; Gabriël J E Rinkel; Jan Willem Berkelbach van der Sprenkel; W Peter Vandertop; Ale Algra; Catharina J M Klijn
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

Review 4.  Cerebral arteriovenous malformations: issues of the interplay between stereotactic radiosurgery and endovascular surgical therapy.

Authors:  Parham Yashar; Arun P Amar; Steven L Giannotta; Cheng Yu; Paul G Pagnini; Charles Y Liu; Michael L J Apuzzo
Journal:  World Neurosurg       Date:  2011 May-Jun       Impact factor: 2.104

5.  A proposed radiosurgery-based grading system for arteriovenous malformations.

Authors:  Bruce E Pollock; John C Flickinger
Journal:  J Neurosurg       Date:  2002-01       Impact factor: 5.115

Review 6.  Radiologic assessment of brain arteriovenous malformations: what clinicians need to know.

Authors:  Sasikhan Geibprasert; Sirintara Pongpech; Pakorn Jiarakongmun; Manohar M Shroff; Derek C Armstrong; Timo Krings
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

7.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

Review 8.  Surgery of cerebral arteriovenous malformations.

Authors:  Nobuo Hashimoto; Kazuhiko Nozaki; Yasushi Takagi; Ken-Ichiro Kikuta; Nobuhiro Mikuni
Journal:  Neurosurgery       Date:  2007-07       Impact factor: 4.654

Review 9.  Partial "targeted" embolisation of brain arteriovenous malformations.

Authors:  Timo Krings; Franz-Josef Hans; Sasikhan Geibprasert; Karel Terbrugge
Journal:  Eur Radiol       Date:  2010-06-11       Impact factor: 5.315

10.  Cerebral proliferative angiopathy: clinical and angiographic description of an entity different from cerebral AVMs.

Authors:  Pierre L Lasjaunias; Pierre Landrieu; Georges Rodesch; Hortensia Alvarez; Augustin Ozanne; Staffan Holmin; Wen-Yuan Zhao; Sasikhan Geibprasert; Dennis Ducreux; Timo Krings
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

  10 in total
  8 in total

Review 1.  Cerebral proliferative angiopathy: Clinical, angiographic features and literature review.

Authors:  Peng Liu; Xianli Lv; Ming Lv; Youxiang Li
Journal:  Interv Neuroradiol       Date:  2015-10-15       Impact factor: 1.610

Review 2.  Cerebral proliferative angiopathy with tumor-like hemorrhage: A case report and literature review.

Authors:  Fatmir Bilaj; Arben Rroji; Eugen Enesi; Maren Ruka; Mentor Petrela
Journal:  Neuroradiol J       Date:  2016-06-20

3.  Recurrent periventricular hemorrhage in cerebral proliferative angiopathy: Case report.

Authors:  Hidetsugu Maekawa; Aiko Terada; Tomoya Ishiguro; Masaki Komiyama; Stephanie Lenck; Leornardo Renieri; Timo Krings
Journal:  Interv Neuroradiol       Date:  2018-07-10       Impact factor: 1.610

4.  Hemorrhagic cerebral proliferative angiopathy in two pediatric patients: case reports.

Authors:  Adalberto Ochoa; Beatriz Mantese; Flavio Requejo
Journal:  Childs Nerv Syst       Date:  2021-05-06       Impact factor: 1.475

5.  Infratentorial hemorrhagic cerebral proliferative angiopathy: A rare presentation of a rare disease.

Authors:  Sunil Kumar; Mukesh Sharma; Trilochan Srivastava; Virendra Deo Sinha
Journal:  Asian J Neurosurg       Date:  2015 Jul-Sep

6.  Diffuse proliferative cerebral angiopathy: a case report and literature review on a very rare and misdiagnosed entity.

Authors:  Sagar Panthi; Nimesh Khanal; Sajana Poudel; Siddhartha Bhandari; Pradeep Khatiwada; Rochana Acharya; Raksha Bhattarai; Bharosha Bhattarai; Sandeep Khanal
Journal:  J Surg Case Rep       Date:  2022-01-18

7.  Hemorrhagic transformation of ischemic cerebral proliferative angiopathy: A case report.

Authors:  Yu Xia; Xian-Feng Yu; Zhen-Juan Ma; Zhong-Wu Sun
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

8.  Acute hemiparesis in a child as a presenting symptom of hemispheric cerebral proliferative angiopathy.

Authors:  J J Gold; J R Crawford
Journal:  Case Rep Neurol Med       Date:  2013-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.